characteristics.text: SAMN17003165
characteristics.characteristic: External Id
characteristics.text: GlaxoSmithKline LLC
characteristics.characteristic: INSDC center name
characteristics.text: 2022-03-01T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2022-03-01T01:58:01.713Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS7832911
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS7832911
characteristics.characteristic: SRA accession
characteristics.text: EBC1
characteristics.ontologyTerms: http://www.ebi.ac.uk/efo/EFO_0003115
characteristics.characteristic: cell line
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: N2
characteristics.ontologyTerms: http://www.ebi.ac.uk/efo/EFO_0004028
characteristics.characteristic: replicate
characteristics.text: Non-small cell lung cancer cell line
characteristics.characteristic: source_name
characteristics.text: EBC1_GSK712_N2_D5
characteristics.characteristic: title
characteristics.text: GSK712
characteristics.characteristic: treatment